Many patients had confounding medical conditions some of which required therapy with agents that have been associated with the development of diabetes mellitus or hyperglycaemia.
Paljudel patsientidel esines ka kaasuvaid haigusseisundeid, mida raviti selliste preparaatidega, mille kasutamisega seoses on esinenud suhkurtõve või hüperglükeemia kujunemist.